Chapter 38: Medication & IV Therapy in Pediatric Nursing

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement, not replace the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

This is where we take the most dense, clinically critical information, stuff that really determines patient safety and deliver it to you as a high impact, actionable summary.

And our deep dive today is,

it's perhaps one of the most high stakes topics in all of healthcare.

I'd agree with that.

We're focusing on pediatric medication and IV administration.

So we're talking about safe, effective techniques and I mean, critically, how to avoid errors that can have just devastating consequences in a child.

And we aren't starting with theory.

We're gonna jump right into a case that I think really defines this entire discussion.

So picture this, you're the nurse in the emergency department.

An eight year old patient comes in, they have Down syndrome and they've just been diagnosed with osteomyelitis.

So a deep, really serious bone infection.

Right, so they need pain relief immediately.

Immediately.

And then long -term antibiotics.

So you offer an acetaminophen tablet and the child, despite being eight years old, immediately spits it out.

You try again, maybe a different approach and they spit it out again.

And the parent confirms, they've never been able to swallow pills.

And that moment right there, that seemingly simple problem, the inability to comply with oral medication,

that is the foundation of this entire deep dive.

It is.

It forces an immediate clinical pivot and it just illuminates the three core challenges of pediatric care.

Children resist,

their physiology is fundamentally unique and their dosing is, well, it's highly complex and uniquely vulnerable to catastrophic errors.

So our mission today is to cut through that complexity.

We're gonna give you the clinical shortcut to pediatric -specific dosing, understand how the nursing process has to be tailored for this population and really master the specialized administration techniques.

Everything from oral medicine compliance all the way to central venous access.

Exactly, the whole spectrum to ensure patient safety at every single step.

So to set the scene, let's quickly establish some core language.

We'll be navigating pharmacokinetics, which is the study of how a drug moves through the body.

And it's broken down into four distinct processes.

First, there's absorption, how the drug gets into the bloodstream.

Then distribution, which is how it reaches the target site.

Then metabolism, so how the body breaks it down, usually in the liver.

And finally, excretion, how the body gets rid of the waste, typically through the kidneys.

And later on, we'll get into the more advanced stuff.

Later, when we're talking about advanced care, we'll touch on IV lines, specifically things like intracaths.

Those are the thin pliable catheters that go into peripheral veins.

And intermittent infusion devices, which people sometimes call saline locks.

And VAPs too.

And vascular access ports, VAPs, which are the ones surgically implanted for long -term therapy.

Okay, let's unpack the first major hurdle, the unique challenge of pediatric medication.

Why can't we just treat children like they're miniature adults?

Well, it all begins with developmental barriers.

I mean, the essential difference is understanding.

The why.

Exactly.

An adult takes a pill because they comprehend the concept of symptomatic relief, of future wellness.

A child, especially a toddler or a preschooler, they just lack that foresight.

They only perceive the immediate experience.

Which means if that experience is intrusive, and we're talking anything rectal, nasal, intramuscular or IV,

they're going to resist.

Sometimes, you know, violently.

Precisely.

And they're not being intentionally difficult.

It's not a behavioral issue.

They're just responding to fear and intrusion.

And when you factor in complexities like cognitive impairment or a developmental delay, like with the eight -year -old in our opening case, the challenge of compliance just becomes exponentially greater.

So you have to pivot everything.

Everything.

Your method, your dose, your explanation.

It has to match their specific developmental and cognitive status, not just their chronological age.

And that leads us directly to the most critical safety issue in pediatric medication, which is the risk of variable dosing.

I mean, children's sizes are just wildly disparate.

You can have a 500 -gram preemie all the way up to a 100 -kilogram adolescent.

There's just no such thing as a standard dose.

None.

Absolutely.

Pediatric meds are dosed almost exclusively based on body weight.

So milligrams per kilogram, MGQG.

And for the really potent drugs.

For drugs with a very narrow therapeutic index, meaning the difference between an effective dose and a toxic dose is razor thin, like certain chemo agents, we have to use the more precise measure of body surface area, BSA.

Measured in milligrams per square meter.

Correct.

The source material really stresses this variability is where deadly errors creep in.

We hear it all the time, the severity of a decimal point error.

Oh, this cannot be overstated.

When you're calculating a tiny dose for a small child, simply placing a decimal point in the wrong spot, say, ordering 3 .6 milliliter instead of 0 .36 millimeter, you've just introduced a 10 -fold dosing error.

A 10 -fold error.

In the adult world, that might cause some discomfort.

In the pediatric world, especially with a potent drug, it is frequently fatal.

The margin for error is, it's nonexistent.

Which puts immense pressure on the preliminary steps of the whole process.

So what is the single most crucial step before the dose calculation even begins?

It's the mandatory conversion of weight.

It has to happen every single time.

Since nearly all clinical drug references are based on the metric system, you must convert the child's weight from pounds to kilograms kilo G before you even think about calculating a dose.

And if you forget that step.

If a child is weighed in pounds on a standard scale and you forget, you'll be performing your calculation based on a weight that is 2 .2 times too high.

The conversion is standard.

One pound equals 2 .2 kilograms.

Miss that and your dose is critically dangerously incorrect.

So that initial weigh -in and the conversion that follows are, I mean, they're arguably the most fundamental safety barriers we have.

They're absolutely non -negotiable.

And beyond the math, we're also dealing with physiological vulnerabilities.

We're not just scaling down adult processes.

We're dealing with systems that are truly fundamentally immature.

And a major vulnerability is the child's inability to report problems.

They can't tell you what's wrong.

Precisely.

An adult can articulate nuances.

I feel a dull ache or my stomach is upset.

A young child can only express these really generalized symptoms like being irritable or fussy or just withdrawing.

So the nurse has to be a detective.

Exactly.

You have to rely heavily on objective observation rather than subjective patient reporting to detect those early signs of an adverse effect.

This clinical vigilance, it connects our daily nursing tasks to these much broader public health objectives.

This is specifically the Healthy People 2030 Goals.

It does.

Our practice supports these national targets directly, particularly when it comes to safety and prevention.

One major goal focuses on the youngest, most vulnerable population, reducing emergency department visits from medication overdoses in children under five.

And the target is pretty ambitious.

It is, a reduction from 25 .6 % down to 16 .6%.

And that's primarily addressed through parent education and safe storage, right?

Exactly.

But the goals also address the opposite end of the spectrum adolescent misuse.

We have goals aiming to significantly reduce adolescent misuse of alcohol,

illicit drugs, and specifically prescription drugs.

What's the target there?

The target reduction for prescription misuse in persons age 12 and older is from 6 .2 % down to 3 .6%.

That's fascinating.

The simple act of giving an antibiotic to a toddler is somehow linked to preventing prescription drug misuse in a high schooler a decade later.

How does a nurse actually bridge that gap?

It's what we call the nursing intervention link.

It's about linking the immediate clinical task to long -term prevention.

So when you're educating parents, the nurse reinforces safe drug storage.

Medicines must be in a locked cabinet or drawer that is elevated and above reach.

Not just out of sight.

Out of sight is not enough for a climbing toddler.

And then for the adolescent goal, the intervention shifts to education on non -pharmacological stress relief, teaching them healthy coping mechanisms to reduce their reliance on or future desire for self -medication.

It's a whole continuum of safety education applied across the lifespan.

Okay, so once we've assessed those initial risks, we enter the structured phase.

The nursing process overview for pediatric therapy.

And I mean, given the complexity and individuality of each child, this framework is just indispensable.

And it begins logically with assessment.

Gathering the critical data.

We start with the physical metrics.

We need the child's weight in kilograms.

That is the absolute foundation for dosing.

And if the dose is based on BSA,

for those potent drugs like chemotherapy, we also need their height.

But the assessment goes way beyond the scale, right?

We have to know what the child is actually capable of doing.

Crucially,

we need the child's developmental status.

This guides everything.

Does this eight -year -old with Down syndrome have the skills to learn to swallow a pill?

Or will we need to switch routes permanently?

Are they old enough and mature enough to use something like a patient -controlled analgesia, PCA pump?

And their developmental stage also dictates the injection sites.

They're the safest site for an IM or IV injection, yes.

So how do we determine the level of explanation we provide to them?

That's where chronologic age versus cognitive level comes in.

You have to respect the child's actual age, of course, but you tailor your explanation to their cognitive level.

If you're explaining a procedure to a 10 -year -old with the cognitive abilities of a five -year -old, you use the language and reassurance that's suitable for a five -year -old.

So they understand enough to cooperate, but aren't overwhelmed.

Precisely.

The subjective data, the history, that also needs to be meticulously gathered.

Yeah, and it's not just about allergies and adverse reactions, though those are obviously paramount.

We need to know their past medication experiences.

Have they had a bad injection experience?

Have they managed long -term medication before?

And critically,

we need the contextual information, family support, and financial access.

That's a huge one.

Huge.

If the family doesn't have the insurance coverage or the funds to afford a $500 monthly prescription, well, that prescription is essentially meaningless.

We have to address that barrier right in the planning phase.

Once that massive data set is collected, we move into problem identification or nursing diagnosis.

What are some common examples that are unique to pediatric medikinia?

They really reflect the disruption that medication causes to a child's normal life.

You'll see diagnoses like sleep deprivation related to hourly IV checks or early morning dosing.

Knowledge deficiency is very common, often related to the parent's lack of understanding about side effects or timing.

And fear.

Fear is pervasive, especially with something intrusive like IV administration.

We also often diagnose health -seeking behaviors in the parent, which is a positive thing.

It indicates they're actively trying to learn and support their child's recovery.

This leads right into outcome identification and planning.

This is where we make the critical decisions about how we're gonna execute the plan.

Exactly.

We apply all the adult rules, the right drug, right dose, right time, but with a pediatric priority, selecting the right form and route for this specific child.

We must always prioritize the least invasive method that will still be effective.

If we can achieve the outcome with a flavored liquid instead of an IM shot, that's the obvious choice.

And the dosing accuracy here requires a final check even after the initial calculation.

Always.

You must meticulously recalculate the dose.

Often this requires a double check by another licensed professional.

Then beyond the calculation, the schedule is vital.

It has to be effective pharmacologically, but we have to plan administration times that accommodate the child's school schedule, their meals, their sleep, without causing too much interference.

And what about education during this planning phase?

It has to be age appropriate, consistent with what other providers have said, and really, really reinforced.

We explain the expected effects, how long it will take to work, what side effects to watch for.

And because parents are often under immense stress in the hospital, we have to provide written referrals to online resources or support groups where they can reinforce that knowledge later on when they're calmer.

Now we move to implementation, ensuring adherence and safety, because the best plan means nothing if it's not followed at home.

This is the absolute crux of the adherence challenge.

While a child is acutely ill or in the hospital, parents are incredibly conscientious.

But once the child feels better or the family returns to the chaos of daily life work, school runs, sports compliance often drops precipitously.

The example of strep throat is the textbook warning for this, isn't it?

It is the most classic and most dangerous scenario.

Strep throat needs a full 10 -day course of antibiotics to ensure eradication.

If the child feels better after three or four days, a busy parent might stop the medication.

And the risk isn't just the infection coming back.

No, that's the critical point.

The incomplete eradication of group A strep risks the child developing a much more serious, non -infectious complication later.

Rheumatic fever, which leads to permanent lifelong damage to the heart valves.

The stakes are incredibly high.

So how do we intervene?

How do we support compliance once they're out of the hospital?

We have to recommend structural interventions,

instructing parents to use visual aids, a medication chart on the fringe, or setting up dedicated smartphone reminders.

This external structure acts as a safety net, making sure that full -dose completion happens even when the pressure of acute illness is passed.

Finally, we evaluate the whole process through outcome evaluation examples.

How do we measure success beyond just the clinical outcome?

Success has to be measurable and relevant to the learning objectives.

So if a child has a chronic condition, the outcome might be.

Child states the need for lifetime thyroid hormone.

If the parent was taught a new skill, it's parents demonstrate the correct measured dose using an oral syringe.

So it's about competence and responsibility.

Exactly.

For an older adolescent, the outcomes focus on safety and integration.

Adolescent creates a schedule accommodating a 4X daily dose around their sports practice, or the really critical one.

Adolescent states understanding not to share or take others' prescription medication.

That's what we're looking for.

That structural framework is essential, but now let's get to the core biology, pharmacokinetics in children.

This is the deep dive into why their bodies handle drugs so differently.

As we established, pharmacokinetics covers that whole journey,

absorption, distribution, metabolism, and excretion.

And the fundamental point is the immaturity of their body systems.

Every single phase of that journey is altered in a child, particularly in newborns and infants, which makes drug action much less predictable.

Let's start with absorption differences.

Besides the child literally spinning out the medicine, what physiological factors get in the way?

Well, there are physical limitations based on the route.

A young child can't really hold a sublingual tablet effectively, it just gets swallowed.

Their small muscle mass limits the appropriate sites for an IM injection, and infants, as you can imagine, are very prone to removing transdermal patches.

But the major difference is the GI tract itself.

It is.

The gastrointestinal tract is immature at birth, which affects pH and transit time, leading to inconsistent absorption.

But even more common are just the standard childhood symptoms, frequent vomiting and diarrhea.

If a child is experiencing either, the drug simply doesn't stay in the GI tract long enough to dissolve and be absorbed.

So the oral dose is basically useless.

It becomes completely ineffective.

Okay, so once it's absorbed, we look at distribution differences.

How does a drug move throughout a child's body differently?

The first factor is fluid content.

Newborns are about 80 % water, and they have more fluid in their interstitial spaces than older children or adults do.

This high fluid volume generally means drugs take longer to distribute, which can slow down the onset of action.

And this brings us to a crucial, really high -stakes concept, albumin binding.

This is one of the most important clinical insights for our listeners.

It absolutely is.

So drugs circulate in two states, free, which is the active state, and bound, which is inactive, usually bound to serum albumin.

Which is produced by the liver.

Right, and this binding action acts as a buffer.

It prevents toxic levels of the active drug from circulating too quickly.

However, newborns have immature livers, and they may not produce enough albumin.

So if there's not enough albumin, the amount of circulating free drug is high, which leads to an increased risk of toxicity.

But the risk gets even worse when you introduce competition for those few binding sites.

And that's where the danger becomes catastrophic.

So consider an infant who is jaundiced, meaning they have high circulating levels of bilirubin.

Bilirubin also binds very strongly to albumin.

If that infant is then given a drug, like an older generation's sulfonamide antibiotic, which competes for the same albumin binding sites,

well, the sulfonamide wins the competition.

So the drug binds, but the displaced bilirubin is now free to circulate.

Exactly.

This newly unbound bilirubin is highly fat -soluble and can cross the blood -brain barrier.

When it enters the brain cells, it destroys their ability to function, resulting in acute bilirubin encephalopathy or kernicteris.

Which is irreversible brain damage.

Irreversible, devastating brain damage.

It leads to cerebral palsy, hearing loss, and potentially death.

So the gravity of avoiding known albumin competitors in jaundiced babies is absolute.

Wait, so is there a way to definitively test for that binding competition before giving the drug?

Or are we just relying on avoiding known competitors like sulfonamides in jaundiced babies?

We're primarily relying on avoiding the known competitors.

When a child is clinically jaundiced, or when we know their albumin levels are low, which is often the case in premature or severely ill neonates, we just don't take that risk.

The nurse's role is so critical in knowing the drug's properties and cross -referencing that against the newborn's baseline physiology.

The danger is so high that avoiding the risk entirely is the only standard of care.

That just underscores the profound difference between pediatric and adult pharmacology.

Are there also circulatory issues that impact distribution?

Yes, newborns often have sluggish or immature peripheral circulation, especially to their extremities.

This limits effective drug distribution to the arms and legs.

We also see distribution problems in older children who have pre -existing cardiovascular disease or are in shock, where poor circulation just limits the drug's ability to get to its target tissues.

Next up is metabolism differences, how the body breaks the drug down.

This seems to be where we find two contradictory states.

Some drugs are broken down too fast and others way too slow.

That's a great way to put it.

We're dealing with a population that can both rapidly burn through some drugs and dangerously hoard others.

On one hand, a child's basal metabolic rate is often faster than an adult's.

For certain drugs, this means they're metabolized and inactivated more rapidly so they actually need to be given more frequently, maybe every four hours instead of every six, to maintain a therapeutic level.

And the opposite problem, the toxicity, comes from the immature liver enzymes.

Correct.

Certain key liver enzymes needed for detoxification just are not fully developed in newborns.

This prevents the metabolism of specific drugs like salicylates, aspirin, and chloramphenicol, and antibiotic.

Without inactivation, these drugs accumulate rapidly and reach toxic levels, causing life -threatening conditions like gray -Baty syndrome with chloramphenicol.

And this risk isn't just in newborns.

No, it also extends to older children with liver disease where their impaired enzymes fundamentally decrease their ability to process and eliminate medication.

Finally, excretion differences, getting the drug and its metabolites out of the body.

The ability to excrete drugs is potentially limited because kidney function might not achieve full maturity until about 12 months of age.

So if the kidneys are immature or damaged by disease, the drug or its metabolites stay in the system longer, again, increasing that risk of toxicity.

So what's the nursing priority here?

Relentless monitoring.

We must meticulously track the child's intake and output, IO.

This is essential to ensure that their kidney function is adequate and that the drug metabolites are being eliminated effectively through their urine.

We also note that some drugs like digoxin are excreted via bile, and sluggish bile formation in newborns can also limit that excretion route.

That physiological background really explains the huge risks.

Now let's return to the practical safeguards, drug safety, storage, and the six rights in practice.

Right.

Given these unique pharmacokinetic vulnerabilities,

children often experience unique or exaggerated side effects.

And we also have to remember that a newborn may suffer adverse effects from drugs taken by the birthing parent during pregnancy or from certain drugs transferred via human milk.

Let's focus on the crucial issue of safe storage of drugs at home.

The demographics of accidental poisoning are very, very specific.

The source material is adamant about this.

The group at the highest risk for self -administration and poisoning is children aged one to three years old.

This age group has the absolute worst combination of skills.

They're developing sophisticated motor skills like climbing and opening containers, but they have zero judgment of danger.

So accidental ingestion is a leading cause of poisoning.

A leading cause in this age group, yes.

So we need to go beyond just telling parents to put medicine out of reach.

We have to emphasize that out of sight is completely insufficient for a creative toddler.

The guidelines require storage in a locked cabinet or a locked drawer elevated above the child's height.

Furthermore, we advise parents never to take medicine in front of their kids because imitation is such a powerful learning tool.

And there's another common safety mistake.

Yes, never prepare medicine in the dark or in poor light.

So many cough syrups and prescription liquids look similar and bad lighting just increases the risk of pouring the wrong volume or misreading the label.

And the rules are equally strict in the hospital setting.

Absolutely, hospital protocol dictates that medication must never be left unattended at the bedside, on a cart, or anywhere a child could get to it.

And this also extends to adolescents who might deliberately take extra doses of pain medication or stimulants.

So vigilance and education about misuse remain constant.

Okay, let's revisit the clinical standard.

The safe administration rules or the seven rights.

This is the foundation.

Right drug, right form, right child, right dosage, right route, right time, right information documentation and observed response.

And while that's crucial everywhere, we have to remember that areas with high pace and frequent interruptions are the most vulnerable to errors.

This means the intensive care units and the emergency departments are where double checking and adherence to these rights are the most critical.

And the most dangerous of the rights is often the right dosage, which requires specialized calculation tools.

As we mentioned, most doses are MGKG.

But for those potent narrow therapeutic index drugs, we use body surface area BSA dosing.

And that relies on the BSA nomogram.

This nomogram is a concept we really need to help our listeners visualize clearly as it's essential for mastery.

Can you describe the physical act of using it?

Sure,

imagine a large paper chart with three vertical lines or columns running parallel.

The far left column is for the child's height.

The far right column is for the child's weight.

And the central column, the one we need, is the BSA in square meters.

To use it, you take a straight edge, a ruler, even the edge of a piece of paper, and you line it up to connect the measurement you found on the left, the height, with the measurement you found on the right, the weight.

Where that straight line crosses the middle column, that is the calculated body surface area.

It's a graph, not a calculation you do by hand.

And it must be used for those highly potent drugs like chemotherapy.

That makes the process much clearer.

Beyond the nomogram, what are the key references nurses must rely on?

We have to use drug manuals specifically for children, like the Harriet Lane Handbook or Neo Facts for Neonates.

And a critical rule that is often overlooked is that we must always prioritize weight -based dosing over age -based dosing.

So if a three -year -old weighs the same as a one -year -old.

They get the dose appropriate for their weight, not their age.

If the dose prescribed doesn't align with the weight -based standards in the drug reference, it must be questioned and reverified with the prescriber, period.

Let's walk through the math for liquid medicine precisely using the fractional dose calculation, the HXQ formula.

This is the daily math for so many nurses.

Right, the formula is desired dose D divided by the strength you have, H, multiplied by the quantity the strength is in.

So let's use the example from the text.

You need to give 90 milligrams of acetaminophen.

You look at the bottle and the supply reads 125 milligrams in five milligrams of liquid.

Okay.

The calculation is 90 milligrams desired divided by 125 milligrams, a half, times five milligrams of quantity.

So 90 divided by 125 is 0 .72.

You multiply 0 .72 by five millirends and your result is exactly 3 .6 millirends.

Precisely 3 .6 millirends.

Now, if a parent tries to measure that 3 .6 millimellor using a kitchen teaspoon at home, what happens?

You introduce an almost guaranteed dosing error.

This is a crucial teaching point.

Kitchen teaspoons are notoriously inaccurate.

They're for eating, not measuring, and their volume can vary by up to 50%.

Parents have to be stressed to use the supplied calibrated dosing cup, an oral medicine syringe, or a dropper, which allows for accuracy down to the tenth of a milliliter.

And if they lose it.

If they absolutely cannot access the supply device, the next best alternative is cooking measuring spoons, which are at least designed for precision.

Moving to right information and cultural respect.

The nurse's education role here is more than just reading a list of side effects.

Oh, it's comprehensive teaching and constant reinforcement.

We review the drug's purpose, its action, specific timing, side effects.

And because parents are often so stressed and overloaded, we have to reinforce the teaching multiple times.

And we need to remember the child too.

Children as young as five or six can identify if they're feeling sick or dizzy, so our education has to include them.

And how do we approach cultural sensitivity in this context?

We have to assess the family's health beliefs, their attitude toward mainstream medicine.

It is vital to specifically ask about the use of herbal or home remedies, often called natural health products.

The things they might not think to mention.

Exactly.

But they might duplicate the effects of the prescribed drug or even counteract it.

And we also have to address financial reality,

making sure the family has the means, the insurance, the co -pays to actually fill the prescription.

Finally, let's revisit right patient safety, the most important rule for identification.

You never ask a child their name as a sole identifier.

They might answer incorrectly or they might not be able to answer at all.

In the clinical setting, we rely on the ID armband, ideally scanned with a barcode, and comparing that with the medication record.

And at home or in a clinic?

In ambulatory or home settings, we rely on the parent or guardian confirming two identifiers, usually the child's full name and date of birth.

Okay, now we move into the actual execution specialized roots of medication administration.

We're addressing the challenge from our opening case, the eight -year -old who can't swallow a pill.

Right, we start with oral administration techniques because that is always the first line choice.

The ability to swallow pills varies greatly, but it generally becomes possible somewhere between six and seven years old.

The rule is simple.

Always ask the child and the parent if they can swallow pills before you even present a tablet.

If we have to give liquid medicine to an infant, what's the safest technique to prevent aspiration?

The infant has to be held upright against your body with their head raised.

Never give medication with the child lying completely flat.

You use an oral syringe or a dropper and place it at the side of the infant's mouth.

Not straight back.

Never straight back.

And you press the plunger slowly, injecting the fluid little by little, giving them time to swallow.

If you go too fast, they'll either spit it out or aspirate.

Restraint, often a gentle mummy rap, may be needed, but comfort and praise have to follow immediately.

For toddlers and preschoolers, compliance is just a massive battle.

What are the key communication guidelines?

The source material has excellent advice on language.

Use firm statements that don't invite refusal.

Say, it's time to take your antibiotic, not can you drink this for me?

The second one gives them the option to say no, which they will take.

But you can give them some control.

You can by offering a secondary choice over a non -essential part.

Do you want milk or water right after your dose?

What are the absolute nevers we must stress to parents?

Never refer to medicine as candy.

This is a fatal mistake.

The child might try to access it later and consume a fatal dose.

Second, don't use threats.

If you don't take this, the doctor will give you a shot.

Or large bribes, as this just teaches them to demand a higher reward next time.

And be honest about the taste.

Be honest.

Yeah.

If it's bitter, mix it with a small amount of applesauce or pudding, but never mix it with a full bottle of milk or a whole jar of food.

They have to consume the entire carrier to get the full dose.

So how do we coach an older child who is trying to master pill swallowing like our eight -year -old?

There's a fantastic technique using small bits of ice chips.

Because they melt rapidly, they won't stick in the throat or create a choking hazard.

You instruct the child to put the chip on the back of their tongue, tip their head slightly, take a sip of water, and swallow.

It helps them practice the motor skill of swallowing something solid without chewing.

And another method.

Pushing the pill into a spoonful of ice cream or pudding, but, and this is key, doing this openly in front of the child.

The goal here is mastery, not deception.

And the safety warning about crushing pills is vital here.

Always, always verify if crushing is safe.

Capsules and enteric -coated tablets must never be crushed or opened.

They're specifically designed to protect the stomach lining or to delay dissolution.

Grushing them destroys that therapeutic mechanism.

Moving to non -oral routes, intranasal administration has grown in popularity, especially in a chaotic setting like the ED.

It has, largely because drugs are absorbed so rapidly across the nasal mucosa.

It offers quick analgesia or sedation without the pain and fear of an injection.

And the technique is all about positioning.

It is.

The child must be on their back.

A school -aged child can hang their head slightly over the bedside, while a preschooler does better with a pillow under the shoulders.

Infants may need a mummy restraint.

And after you instill the drops?

You instill the drops, then turn the child's head to the side of the administered nostril for at least one full minute.

That retention time is necessary for maximum absorption.

And also remember that nasal sprays must be individually prescribed to prevent cross -contamination.

Next, ophthalmic eye drop sointment administration.

This is frightening for any child.

It has a high fear factor, high risk of reflex avoidance.

Restraints are typically needed for infants and preschoolers.

We instill drops into the conjunctival sac of the lower lid, gently pulling the lid down to create a little pocket.

And crucially, we avoid placing the drops directly onto the sensitive cornea.

How does the technique change for an ointment, especially in an eye with discharge?

For ointment, you apply a fine line from the inner canthus, near the nose, to the outer canthus.

We apply it in this direction, never pressing toward the midline, especially if there's pus, because this prevents forcing the infection across the eyeball or down the lacrimal duct.

For attic ear drops administration, the safety alert is completely non -negotiable.

The drops must be warmed to room temperature or slightly warmer.

Cold fluid touching the campanic membrane is intensely painful and can induce severe vertigo, causing dizziness and vomiting.

And the mastery alert for the technique involves age differentiation.

This is a critical distinction.

It is, and it's one of those things you just have to memorize.

The child's head is turned sideways to straighten the ear canal.

For children younger than two years, you pull the pin down and back.

For children older than two years, you pull the pin up and back.

And the head has to remain turned for several minutes to retain the drops.

Rectal administration can be highly effective when other routes are unavailable.

Yes, for things like anticonvulsants or antipyretics, when there's vomiting or the child is unconscious,

absorption can be inconsistent.

But the major challenge is that it's highly invasive and frightening because the child can't see what's happening.

So what's the technique?

You show the child the suppository beforehand,

reassure them it's not a shot, then you lubricate it and insert it quickly beyond the rectal sphincters.

For an infant, it's about half an inch deep.

For an older child, about one inch.

And immediately after, you have to hold their buttocks together for about 10 seconds to prevent expulsion.

Finally, transdermal topical administration.

Topical creams are generally well tolerated.

Hand hygiene after is paramount.

For transdermal patches, they should be placed on the trunk or a major muscle group, avoiding distal extremities where absorption is poor,

sites have to be rotated, and the skin assessed.

The big safety risk here is that young children may remove and chew the patches, which can lead to massive drug toxicity.

Now for injections and continuous infusion devices.

Starting with intramuscular IAM administration.

It's rare in hospitalized kids due to the pain and minimal muscle mass, but the site selection rules are crucial for immunizations.

They are critical for safety.

For infants and children under walking age, the required site is the vastus lateralis muscle on the lateral aspect of the thigh.

We have to strictly avoid the gluteal muscle, the buttock, until the child has been walking for at least a year.

Because of the sciatic nerve risk.

The very real risk of sciatic nerve damage.

For older walking children, the deltoid or ventral gluteal site can be used as long as there's adequate muscle mass.

Given the fear, what are the best techniques for pain management during an injection?

First, never inject a child while they're sleeping.

That just makes sleep a source of anxiety.

To reduce the sharp initial pain, an anesthetic cream like EMLA should be applied some minutes before.

Once you decide to do it, administer the injection quickly after a brief honest explanation.

And the language we use is so vital for coping.

We have to validate their feeling.

Don't tell them be brave or don't cry.

Instead, acknowledge the pain.

It's okay to cry or scream or squeeze my hand.

Distraction is the gold standard.

Singing, counting, squeezing a toy or guided imagery.

And meticulous documentation.

Yes, record the specific site of injection to ensure proper rotation for better absorption.

Moving to non -IV continuous delivery, subcutaneous pump infusion.

This is used for constant stable drug delivery, typically insulin for type one diabetes or certain anticoagulants.

And modern practice couples these insulin pumps with continuous glucose monitoring or CGM technology.

Which significantly enhances safety.

Greatly, it provides real -time data and alarms for dangerously low or high glucose levels.

What are the practical instructions for parents using these pumps?

The site is usually the abdomen.

A small needle is inserted at a 45 degree angle.

The catheter is left in place.

And it's changed about every three days.

Crucially, the pump has to be disconnected for swimming or tub bathing.

And they're generally not recommended for children who are not yet reliably toilet trained because of the risk of soiling the site.

We should also briefly mention auto -injection syringes.

Right, these are pre -filled, quick, small, excellent tools for emergency self -injection.

Like EpiPens for allergic reactions.

Kids as young as five or six can be trained to use them correctly.

This brings us to section seven.

Intravenous therapy and access devices, which is really the cornerstone of critical pediatric care.

It is.

4V therapy is essential for moderate to severe dehydration, for achieving rapid therapeutic drug levels, like the antibiotics for our eight -year -old's osteomyelitis and for nutritional support.

While oral rehydration is preferred for mild cases, IVs are necessary when there's persistent vomiting or severe illness.

What are the primary risks we have to assess constantly?

Because kids are so mobile, the risks are constant.

Infiltration, which is fluid leaking into the tissue, dislodgement, and infection.

Infiltration has to be assessed hourly, looking for swelling, coolness, or pain at the site.

Infection requires sterile dressing changes.

We often use gauze or specialized wraps to protect the site from curious toddlers, but frequent inspection is non -negotiable.

Let's talk about fluid needs and safety.

What are the rules for the type of fluid?

The fluid must be isotonic, meaning it has the same osmotic pressure as the blood to prevent red blood cell damage.

0 .9 % normal saline is the most common one.

We must rigorously avoid hypotonic fluids, as this carries a severe risk of hyponatremia and potentially fatal water intoxication.

Hypertonic fluids, like mannitol, are only used in highly controlled situations, like relieving cerebral edema.

The universal standard for calculating maintenance fluid is the 150 -20 rule.

Can you walk us through that specific calculation?

This is essential for our listeners to master.

This rule calculates the child's necessary fluid intake over 24 hours based on their weight in kilograms.

Let's use the example of a 26 -kilogram child.

So the first 10 kilograms, they require 100 milliliters for every kilogram.

So that's 10 times 100, which is 1 ,000 milliliters.

For the next 10 kilograms, they require 50 milliliters for every kilogram.

There's another 10 times 50, which is 500 milliliters.

And for the rest.

And for the remaining weight, which is six kilograms, in this case, they require 20 milliliters for every kilogram.

So six times 20 is 120 milliliters.

You add it all up, 1 ,000 plus 500 plus 120 give you a total of 1 ,620 milliliters for the 24 -hour requirement.

That's the total volume.

To set the IV pump, we need the hourly rate.

You just divide that total by 24 hours.

So 1 ,620 milliliter divided by 24 hours equals 67 .5 milliliter.

We'd set the pump to run at 68 milliliter.

And maintenance fluids usually contain dextrose 5%, selenium 0 .9%, and 20 milliliter potassium per liter.

Access is a huge hurdle.

What are the common venous access sites?

We use very small needles, 22 gauge up to 27 gauge.

Peripheral sites are the hands, wrists, feet.

But in infants, especially when other sites fail, we have to use the scalp vein over the temporal area.

Which can be really unsettling for parents.

Very, it looks dramatic.

So the nurse has to reassure them that the vein is superficial and that this site often infiltrates less because the infant can't move their head as freely as their limbs.

Offering to save the hair clippings is a small but important gesture.

And we often use arm boards to secure peripheral IVs and prevent removal.

Since their cardiovascular system is so small, we have to carefully manage the infusion rate to prevent fluid overload.

This is critical.

Infusion pumps are mandatory because we have to regulate the rate to just a few drops per minute.

And to prevent a disaster if the pump fails, a vital safety measure is the use of fluid chambers.

These are drip chambers that limit the volume in the primary reservoir to only 50 to 100 milliliter at a time.

This prevents a massive life -threatening fluid overload if the system malfunctions.

What are the cardinal signs of fluid overload that a nurse must recognize immediately?

We look for signs of early congestive heart failure, coarse crackling breath sounds, a rapid increase in pulse rate, noticeable edema, and often a slight drop in blood pressure.

And at the same time, we're continuously monitoring IO with target urinary output rates, two millikalior AGR for infants, and 0 .5 to one millikalior AGR for older children.

What evidence -based practice can we use to manage the child's distress during these long infusions?

Distraction is key.

We provide quiet activities.

But research is showing that integrating technology, specifically virtual reality, VR, can significantly reduce a child's pain perception and anxiety during IV insertion or other long procedures by just immersing them in a calming three -dimensional world.

When administering IV medications, how do we typically run them?

First, always check compatibility with the maintenance fluid.

MIDS can be given as a rapid bolus, often with a syringe pump, or more commonly as a piggyback infusion.

We rely on smart infusion pumps, SIPs, which have programmed guardrails to prevent nurses from accidentally entering a dangerously high dose.

And patient -controlled analgesia, PCA pumps, are safe for children who are developmentally capable of understanding them as long as they have preset lock -ad intervals.

For kids who are mobile but still need IV access, we use intermittent infusion devices.

Known universally as saline locks.

They maintain open venous access without requiring continuous fluid.

They're flushed regularly to maintain patency and are a huge benefit because they grant the patient significant mobility.

And finally, for children who need treatment for weeks or months like antibiotics for severe osteomyelitis, we move to central venous access.

There are three main types.

First, tunnied catheters like a Broviac or Hickman.

These are surgically inserted into the vena cava and exit through a tunnel on the chest.

They have a dacron cuff that tissue grows into, sealing the site and preventing infection.

The risks are profound, air embolus and massive hemorrhage if it's disconnected.

So secure connections and sterile dressing changes are paramount.

Next are vascular access ports or VAPs.

Right, or infusor ports.

These are implanted entirely under the skin, usually on the anterior chest.

The huge practical advantage is that when they're unaccessed, there's no external site so the child can swim or shower.

But accessing the port requires a specialized non -coring needle to prevent damaging it.

And the one preferred for home use, PICC lines.

Peripherally inserted central catheters, inserted into an arm vein and threaded until the tip rests in the superior vena cava.

They can stay in for up to four months, making them highly suitable for extended home antibiotic therapy.

For all central lines, no matter the type, strict aseptic technique is the single most important intervention to prevent infection, air embolism, and thrombosis.

Our final route is the emergency measure.

Intraosseous, IO, infusion.

This is used exclusively in critical, life -threatening emergencies, severe shock, extensive burns when peripheral fibia access is impossible.

The infusion is delivered directly into the bone marrow cavity, usually the tibia.

Because the bone marrow is so vascular, the fluid reaches the circulation just as quickly as a peripheral fight.

It sounds like an immediate last resort.

It is temporary and highly painful.

It requires local anesthetic and often a power -assisted device, like an easy IO drill for rapid insertion.

And it's temporary because of the high risk of osteomyelitis, a serious bone infection.

Once it's running, the nursing priority is intense monitoring, hourly assessment of the distal pulse, temperature, and color of the extremity to ensure adequate circulation.

So to synthesize the core learning from this deep dive, we have to remember the six fundamental principles for safe pediatric medication.

First, always rely on weight -based or BSA -based dosing and master that Pound -Sakee conversion.

Second, fully grasp the pharmacokinetic differences, especially the immature liver and kidney function that dictate increased toxicity risk, like with that albumin binding competition.

Third, recognize that developmental status mandates the selection of the right form and route.

Right, and fourth, use precise measuring tools like the oral syringe and strictly enforce those locked, elevated storage rules at home.

Fifth, manage pain and fear through distraction and honesty.

And sixth, when complex access is needed, ensure mastery of specialized devices, whether that's a pump -controlled peripheral IV, an intermittent saline lock for mobility, or long -term central access like a VAP.

And always, always adhere to strict aseptic technique and vigilance against fluid overload.

Thinking back to our eight -year -old child with Down syndrome and osteomyelitis, they need long -term healing, and that means long -term antibiotic compliance after discharge, likely with liquid medication or a practice pill -swallowing technique.

The nurse who provides this comprehensive care ensures not only immediate healing, but long -term safety.

And my final thought and challenge for you, the listener, connects this to the broader public health mission embodied by the Healthy People 2030 goals.

If the nurse teaches the parents the importance of the full antibiotic course and the technique for measuring the liquid dose accurately, how can they leverage that immediate care encounter and the parents' desire for healing to also address the goals of preventing accidental poisoning in the child's younger siblings, while also laying the foundation for preventing intentional prescription misuse when this child becomes an adolescent?

The answer lies in that safety education about lock storage.

It connects the clinical moment to the public health future, a powerful reminder that every clinical interaction is an opportunity for lasting public safety education.

Thank you for joining us for this crucial deep dive into the specifics of pediatric medication safety.

We look forward to connecting the dots for you next time.